Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Hanke

Showing results (41-50 of 289) with videos related to

Pageof 29
Sort By:
Journal of the American Heart Association|June 11, 2024
Achieving an Optimal Outcome After Stage 1 Palliation for Hypoplastic Left Heart Syndrome and Variants: Frequency, Associated Factors, and Subsequent OutcomesKhayri Shalhoub, Haleh C Heydarian, Samuel P Hanke, et al.
Joint Commission Journal on Quality and Patient Safety|June 5, 2019
Development of a System to Measure and Improve Outcomes in Congenital Heart Disease: Heart Institute Safety, Quality, and Value ProgramKatherine Clarke-Myers, David S Cooper, Samuel P Hanke, et al.
Nature Communications|January 26, 2020
Topological-chiral magnetic interactions driven by emergent orbital magnetismS Grytsiuk, J-P Hanke, M Hoffmann, et al.
The British Journal of Cancer. Supplement|July 1, 1990
Tumour imaging of bladder carcinomas and their metastases with 111indium-labelled monoclonal anti-CEA antibody BW 431/26W Boeckmann, R P Baum, H Schuldes, et al.
Journal of the American Heart Association|May 9, 2020
Angiotensin-Converting Enzyme Inhibitor Prescription for Patients With Single Ventricle Physiology Enrolled in the NPC-QIC RegistryJesse E Hansen, David W Brown, Samuel P Hanke, et al.
The Netherlands Journal of Medicine|January 1, 1985
Treatment of steroid-resistant rejections with ATG and/or plasma filtration improves graft survival rates after cadaveric kidney transplantationW Fassbinder, P B Bechstein, H J Stutte, et al.
Congenital Heart Disease|May 9, 2017
Predicting long-term mortality after Fontan procedures: A risk score based on 6707 patients from 28 studiesTarek Alsaied, Jouke P Bokma, Mark E Engel, et al.
Heart (British Cardiac Society)|January 7, 2017
Factors associated with long-term mortality after Fontan procedures: a systematic reviewTarek Alsaied, Jouke P Bokma, Mark E Engel, et al.
Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association|January 1, 1983
Renal allograft survival in patients transfused perioperatively onlyW Fassbinder, U Frei, E H Scheuermann, et al.
Applied Clinical Informatics|November 15, 2019
Usability Testing of an Interactive Dashboard for Surgical Quality Improvement in a Large Congenital Heart CenterDanny T Y Wu, Scott Vennemeyer, Kelly Brown, et al.
Pageof 29

Showing results (41-50 of 289) with videos related to

Sort By:
Pageof 29
Journal of the American Heart Association|June 11, 2024
Achieving an Optimal Outcome After Stage 1 Palliation for Hypoplastic Left Heart Syndrome and Variants: Frequency, Associated Factors, and Subsequent OutcomesKhayri Shalhoub, Haleh C Heydarian, Samuel P Hanke, et al.
Joint Commission Journal on Quality and Patient Safety|June 5, 2019
Development of a System to Measure and Improve Outcomes in Congenital Heart Disease: Heart Institute Safety, Quality, and Value ProgramKatherine Clarke-Myers, David S Cooper, Samuel P Hanke, et al.
Nature Communications|January 26, 2020
Topological-chiral magnetic interactions driven by emergent orbital magnetismS Grytsiuk, J-P Hanke, M Hoffmann, et al.
The British Journal of Cancer. Supplement|July 1, 1990
Tumour imaging of bladder carcinomas and their metastases with 111indium-labelled monoclonal anti-CEA antibody BW 431/26W Boeckmann, R P Baum, H Schuldes, et al.
Journal of the American Heart Association|May 9, 2020
Angiotensin-Converting Enzyme Inhibitor Prescription for Patients With Single Ventricle Physiology Enrolled in the NPC-QIC RegistryJesse E Hansen, David W Brown, Samuel P Hanke, et al.
The Netherlands Journal of Medicine|January 1, 1985
Treatment of steroid-resistant rejections with ATG and/or plasma filtration improves graft survival rates after cadaveric kidney transplantationW Fassbinder, P B Bechstein, H J Stutte, et al.
Congenital Heart Disease|May 9, 2017
Predicting long-term mortality after Fontan procedures: A risk score based on 6707 patients from 28 studiesTarek Alsaied, Jouke P Bokma, Mark E Engel, et al.
Heart (British Cardiac Society)|January 7, 2017
Factors associated with long-term mortality after Fontan procedures: a systematic reviewTarek Alsaied, Jouke P Bokma, Mark E Engel, et al.
Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association|January 1, 1983
Renal allograft survival in patients transfused perioperatively onlyW Fassbinder, U Frei, E H Scheuermann, et al.
Applied Clinical Informatics|November 15, 2019
Usability Testing of an Interactive Dashboard for Surgical Quality Improvement in a Large Congenital Heart CenterDanny T Y Wu, Scott Vennemeyer, Kelly Brown, et al.
Pageof 29